4-MEC Stats & Data

4‑MEC is a synthetic cathinone with a short human use history; availability often followed mephedrone controls and products may be mislabelled or adulterated (e.g., sold as 3‑MMC or even ketamine), so test before use and titrate cautiously. 4‑MEC likely acts as a mixed monoamine stimulant/entactogen; as with serotonergic cathinones like 4‑MMC, combining with MAOIs or serotonergic agents (SSRIs/SNRIs, tramadol, DXM) increases risk of serotonin toxicity and should be avoided. Stimulant risks include tachycardia, hypertension, hyperthermia, vasoconstriction, bruxism, and insomnia; risk rises with dose and rapid redosing. Insufflation causes local irritation and, with repetition, can damage nasal mucosa; use your own clean utensil, saline rinse, switch nostrils, and rest the nose. Injecting cathinones adds significant harm (vein and tissue injury, infection) and can encourage compulsive redosing; if someone proceeds despite risks, sterile technique (new syringe, sterile water, filtration, site prep) reduces—but does not remove—harms. Redose compulsion (“fiending”) is frequently reported; spacing use (e.g., multiple weeks) reduces neuro/psychological stress and helps sleep and nutrition recover. The same name (‘4‑MEC’) has appeared in branded blends (e.g., ‘NRG‑2’) and non-analysed powders; do not assume purity or identity without drug checking. Formal pharmacokinetics (e.g., half-life) in humans remain poorly defined; expect variability across batches and individuals. Compared with 4‑MMC, 4‑MEC is often described as less potent and somewhat more sedating by users, but objective potency and toxicity data are limited—dose conservatively.